P. ostreatus | FD, DAD | Untreated: (28.70 ± 0.71)%, DAD: (14.58 ± 0.58)%, FD: (22.75 ± 0.56)% | — | — | — | FD is more conducive to preserving the bioactive proteins and polysaccharides of P. ostreatus. | [23] |
C. militaris | HD, ID, FD | ID: 3.61%,FD: 2.60%, HD: 2.19% | Uronic acid: FD: 26.55%, HD: 21.73%, ID: 20.55% | — | Neutral sugar: FD: 85.58%, HD: 73.23%, ID: 67.92% | Immunomodulatory, antioxidant, anti-tumor, and hypoglycemic pharmacological activities | [24] |
P. eryngii | FD, OD | FD: (7.31 ± 0.15)% | Total phenol: (1.589 ± 0.117)%, | — | Glc: FD: 88.90%, OD: 87.68%; Man: FD: (5.75 ± 0.05)%, OD: (5.52 ± 0.41)%;Gal: FD: (5.34 ± 0.30)%, OD: (5.17 ± 0.02)% | Stronger ABTS radical scavenging activity in FD compared to OD | [25] |
C. sinensis | FD | 0.185% | — | — | — | Strong antioxidant activity | [26] |
L. curvatus SJTUF 62116 | FD | 0.02% | — | 4.43 × 104 | Glucosamine, Glu, Man, glucuronic acid | Antioxidant, antitumor, promotes probiotic colonization, lowers blood sugar | [31] |
L. fermentum S1 | FD | — | No uronic acid | 7.19 × 105 | Man, Rha, glucose, galactose | Strong antioxidant activity, modulates oxidative stress in nematodes | [32] |
C. militaris | HD, ID, VFD | HD: 2.19%, ID: 3.61%, VFD: 2.60% | FD: 26.55%, HD: 21.73%, ID: 20.55% | — | Neutral sugar FD: 85.58%, HD: 73.23%, ID: 67.92% | Immunomodulatory, antioxidant, antitumor, and hypoglycemic activities | [6] |
A. auricula | HD, ID, FD, MD | FD: (94.06 ± 0.44)%, HD: (93.85 ± 0.31)%, ID: (96.74 ± 0.43)%, MD: (91.51 ± 1.15)% | FD: 33.53%, HD: 31.00%, ID: 24.33%, MD: 32.53% | FD: 4.07 × 105;HD:1.03 × 106 and 1.72 × 105;ID: 1.00 × 106 and 3.90 × 105,MD: 1.56 × 106 and 3.26 × 105 | Galactose, glucose, Man, glucuronic acid, xylose | Strongest antioxidant activity in FD | [33] |
Spent L. edodes substrate | FD, VD, SD | MD:13.00%, VD: 8.69%, SD: 10.68% | FD:(6.88 ± 0.09)%; VD:(0.43 ± 0.03)%SD:(0.41 ± 0.07)% | — | FD: Ara:Xyl:Man:Glc:Gal = 54:26:3:11:6 | Highest yield and antioxidant activity in FD | [34] |
Cs-4 fungus | FD | Extracellular polysaccharides: 6.95%, intracellular polysaccharides: 3.65%, purified extracellular polysaccharides: 2.87%, purified intracellular polysaccharides: 0.75% | — | — | EPSP and IPSP monosaccharide composition is mainly fucose, arabinose, galactose, Glu, xylose, Man, and Rib. Arabinose, galactose, Glu, and Man are the main monosaccharides | Significantly inhibit collagen-induced human platelet activation and aggregation, reduce CD62p expression and αIIbβ3 activity on platelet surface. EPSP, IPSP, and their metabolites can also inhibit thrombosis formation in vivo | [39] |
T. fuciformis | US + MVD, USMVD, HD | Fresh: 9.42%, HD: 5.80%, MVD: 5.87%, US + MVD: 6.07%, 6.15%, 6.25%, USMVD: 6%, 6.35%, 6.75% | — | Fresh: 1.64 × 105, HD: 2.97 × 105, MVD: 187.92, US + MVD: 1.72 × 105, 1.94 × 105, 2.16 × 105 USMVD: 1.78 × 105, 2.10 × 105, 2.21 × 105 | Mainly composed of fucose, arabinose, Rha, Glu, Man, and Xyl | Multiple bioactivities including antioxidant, anti-tumor, anti-aging, immunomodulatory, and hypoglycemic effects | [41] |
L. edodes | HD, ID, VFD, IHD, PVD, RHD | IHD: 24.07%, RHD: 19.77%, PVD: 18.55%, HD: 16.24%, Fresh: 28.85% | IHD: (15.46 ± 0.78)%, RHD: (13.93 ± 0.31)%, PVD: (10.39 ± 0.56)%, HD: (7.72 ± 0.34)%, Fresh: (17.21 ± 0.89)% | — | — | IHD increases antioxidant properties | [47] |
A. blazei LPB 03 | FD, VD, SD | FD: 97.36%,VD: 93.23%, SD: 42.31% | — | — | — | Significant inhibition of Ehrlich tumor cell viability | [46] |
T. fuciformis | CD (18 °C cold air), HD (50 °C), FD | FD: 15.35%,CD: 15.60%,HD: 16.10% | — | FD: 2.06 × 107;CD: 2.41 × 107HD: 2.34× 107 | — | High thermal decomposition performance | [50] |
Spent L. edodes substrate | FD, VD, SD | FD: 13.00%, VD: 8.69%, SD: 10.68% | FD: (6.88 ± 0.09)%, VD: (4.28 ± 0.32)%, SD: (4.13 ± 0.06)% | FD: 1.68 × 104 | FD: Ara:Xyl:Man:Glc:Gal = 54:26:3:11:6 | Antioxidant activity | [60] |
Pleurotus geesteranus | VFD | Polysaccharide content: (83.23 ± 0.38)% | — | Number average molecular weight: 4.87 × 106, weight average molecular weight: 9.8 × 106 | Fuc, Ara, Gal, Glc, Xyl, Man, Rib, Gal-AC, Glc-AC | Enhances body’s antioxidant capacity, inhibits oxidative stress and inflammation, regulates lipid metabolism, reduces lipid accumulation, and regulates immunity through multiple signaling pathways (Keap1/Nrf2, AMPK/SREBP, TLR4/NF-κB) | [68] |